Transjugular Intrahepatic Portosystemic Shunt

Abstract

Chronic liver disease is the 11th leading cause of mortality in the United States. 1 Portal hypertension is a common endpoint for progressive liver disease, and can clinically manifest as refractory ascites, splenomegaly, and life-threatening esophageal and gastric variceal bleeding. Transjugular intrahepatic portosystemic shunt (TIPS) is an endovascular procedure that treats portal hypertension by making a connection between the portal and systemic venous systems. By creating a low-resistance outflow tract for portal venous drainage, TIPS decreases portal hypertension and its dangerous sequelae in patients not responding to medical therapy.Creation of transjugular intrahepatic portosystemic shunt (TIPS) dates to the 1960s, when Josef Rosch, a successful